Back to search

Article

Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals

2022-05-11

Abstract excerpt

The binding of the SARS-CoV-2 spike to angiotensin-converting enzyme 2 (ACE2) promotes virus entry into the cell. Targeting this interaction represents a promising strategy to generate antivirals. By screening a phage-display library of biosynthetic protein sequences build on a rigid alpha-helicoidal HEAT-like scaffold (named αReps), we selected candidates recognizing the spike receptor binding domain (RBD). Two o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
faf14c91-f561-5802-bd3d-a724025044a3
DOI
10.1101/2022.05.10.491295
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-viralsDOI 10.1101/2022.05.10.491295
Select a neighboring publication to make it the new centre.